Glenmark Pharmaceuticals Ltd Financials

Glenmark Pharmaceuticals Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln LrgNSE
₹2,166.60
-31.90(-1.45%)
As on 23 Oct 2026 at 15:59
As of 23 Oct 2026 at 15:59, Glenmark Pharmaceuticals Ltd is trading at ₹2,166.60. The 52-week range stands at ₹1,792.60–₹2,537.60, with a market cap of ₹60.10 thousand crore. At a P/E of 41.17 and a dividend yield of 0.23%, it is a large-cap stock in the Pharmaceuticals sector.

Glenmark Pharmaceuticals Ltd Financial Statements

02,0004,0006,0008,00010,000₹7,891FY24+16.92%₹9,226FY25-8.52%₹8,440FY26

*All values are in INR Crore

Frequently asked questions

The Glenmark Pharmaceuticals Ltd revenue for the latest reported period is ₹8,440 crore, compared with ₹9,226 crore in the previous period.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now